Modern Healthcare1 天
Uncertainty in Washington rattles telehealth sector
Telehealth companies, used to reimbursement uncertainty dating back to the start of the COVID-19 pandemic, say this time is ...
Hims & Hers stock surges 23%: Telehealth company announces expansion into blood testing ...
Hims’s acquisition of Trybe Labs will put it in competition with health industry juggernauts such as Labcorp and Quest ...
Hims & Hers Health (HIMS) Upward Trajectory Boosted by Recent Acquisition
Telehealth pioneer Hims & Hers Health (HIMS) stock is soaring, with a 12% gain in recent days and a whopping 176% in the last ...
Fierce Healthcare1 天
FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
MM&M4 天
How new direct-to-consumer platforms are changing pharma’s relationships with patients
New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with ...
Hims & Hers to offer at-home blood draws and lab testing with new acquisition
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
Why Hims & Hers Health Stock Is Skyrocketing Today
Shares of Hims & Hers Health Inc ( HIMS 17.50%) are flying higher on Wednesday. The company's stock gained 21.7% as of 2:00 p ...
Modern Healthcare1 天
Hims & Hers' stock plunges as semaglutide shortage ends
The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...
RiverBender.com2 天
Durbin, Marshall Introduce Protecting Patients From Deceptive Drug Ads Act
WASHINGTON U.S. Senate Democratic Whip Dick Durbin (D-IL) and U.S. Senator Roger Marshall, M.D. (R-KS) today introduced the ...